rethinkPeptides Search
Menu
Research citation

Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial.

Reproductive biology and endocrinology : RB&E, 23(1), 108

Citation

Chen, Haiyan; Lei, Xiaohui; Yang, Zhuoran; Xu, Yuxin; Liu, Dongfang; Wang, Cong; Du, Hu. (2025). Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial.. Reproductive biology and endocrinology : RB&E, 23(1), 108. https://doi.org/10.1186/s12958-025-01447-3